Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegileridine vs sufentanil for postoperative analgesia in elderly colorectal tumor patients
ChiCTR2500115217Phase 4Not yet recruiting
- Sponsor
- Cancer Hospital of Guangxi Medical University
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of tegileridine in colorectal cancer (CRC) (2 arms), sponsored by Cancer Hospital of Guangxi Medical University. Primary endpoint: Quality of recovery score on postoperative day 1. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
tegileridine
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on ChiCTR2500115217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500115217.